Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.61 USD | +1.06% | +15.12% | +18.95% |
09/05 | Earnings Flash (ATRA) ATARA BIOTHERAPEUTICS Reports Q1 Revenue $27.4M | MT |
01/04 | Stifel Adjusts Atara Biotherapeutics Price Target to $2.30 From $4.80, Maintains Hold Rating | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+18.95% | 7.27Cr | |
+9.42% | 11TCr | |
+11.84% | 10TCr | |
-14.15% | 2.24TCr | |
-1.05% | 2.23TCr | |
-5.29% | 1.91TCr | |
-38.29% | 1.8TCr | |
-4.16% | 1.79TCr | |
+7.99% | 1.43TCr | |
+36.24% | 1.25TCr |
- Stock Market
- Equities
- ATRA Stock
- News Atara Biotherapeutics, Inc.
- Transcript : Atara Biotherapeutics, Inc. Presents at Morgan Stanley 16th Annual Global Healthcare Conference, Sep-12-2018 02